BMS Keeps Focus On Growth, Continues Trump Administration Negotiations

Investors Watching For Late 2025 Cobenfy Readout

 
• By Mandy Jackson
  
Medicare drug price negotiations under the IRA for Pomalyst in 2027 are also under way (Shutterstock)

More from Scrip

More from Earnings